NCT04675255View on ClinicalTrials.gov

Assessing the Impact of INSTI to PI Switch on Insulin Sensitivity and Fat Metabolism

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

June 8, 2023

Study Completion Date

June 8, 2023

Conditions
HIV I InfectionAdiposity
Interventions
PROCEDURE

Frequently sampled glucose tolerance testing

Frequently sampled glucose tolerance testing

PROCEDURE

abdominal subcutaneous adipose tissue biopsy

abdominal subcutaneous adipose tissue biopsy

PROCEDURE

MRI scan to assess intrahepatic triglyceride content

MRI scan to assess intrahepatic triglyceride content

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
collaborator

Janssen Scientific Affairs, LLC

INDUSTRY

lead

Washington University School of Medicine

OTHER

NCT04675255 - Assessing the Impact of INSTI to PI Switch on Insulin Sensitivity and Fat Metabolism | Biotech Hunter | Biotech Hunter